A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

relapsed and/or refractory mature t cell malignancy, peripheral t-cell lymphoma, angioimmunoblastic t-cell lymphoma, anaplastic large cell lymphoma, hepatosplenic t-cell lymphoma, monomorphic epithelialtropic intestinal lymphoma, enteropathy associated t-cell lymphoma, cutaneous t-cell lymphoma, mycosis fungoides, subacute panniculitis-like t-cell lymphoma, ccr4, car t